| Literature DB >> 25071522 |
Charles-Etienne Benoit1, Simone Dalla Bella2, Nicolas Farrugia3, Hellmuth Obrig4, Stefan Mainka5, Sonja A Kotz6.
Abstract
It is well established that auditory cueing improves gait in patients with idiopathic Parkinson's disease (IPD). Disease-related reductions in speed and step length can be improved by providing rhythmical auditory cues via a metronome or music. However, effects on cognitive aspects of motor control have yet to be thoroughly investigated. If synchronization of movement to an auditory cue relies on a supramodal timing system involved in perceptual, motor, and sensorimotor integration, auditory cueing can be expected to affect both motor and perceptual timing. Here, we tested this hypothesis by assessing perceptual and motor timing in 15 IPD patients before and after a 4-week music training program with rhythmic auditory cueing. Long-term effects were assessed 1 month after the end of the training. Perceptual and motor timing was evaluated with a battery for the assessment of auditory sensorimotor and timing abilities and compared to that of age-, gender-, and education-matched healthy controls. Prior to training, IPD patients exhibited impaired perceptual and motor timing. Training improved patients' performance in tasks requiring synchronization with isochronous sequences, and enhanced their ability to adapt to durational changes in a sequence in hand tapping tasks. Benefits of cueing extended to time perception (duration discrimination and detection of misaligned beats in musical excerpts). The current results demonstrate that auditory cueing leads to benefits beyond gait and support the idea that coupling gait to rhythmic auditory cues in IPD patients relies on a neuronal network engaged in both perceptual and motor timing.Entities:
Keywords: Parkinson disease; auditory cueing; motor behavior; perception; timing
Year: 2014 PMID: 25071522 PMCID: PMC4083221 DOI: 10.3389/fnhum.2014.00494
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Demographic and clinical characteristics for IPD patients and healthy controls.
| Patients | Controls | |||
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | |||
| Females | – | 5 | – | 10 |
| Males | – | 10 | – | 10 |
| Right | – | 15 | – | 20 |
| Age | 67.2 (7.5) | 15 | 66.4 (7.8) | 20 |
| Years of education | 14.7 (2.7) | 15 | 14.4 (3.0) | 20 |
| Age at onset | 59.3 (7.4) | 15 | – | – |
| Disease duration | 7.9 (2.7) | 15 | – | – |
| UPDRS | ||||
| I (mentation, behavior, and mood) | 2.47 (1.8) | 15 | – | – |
| II (activities of daily living) | 12 (6.11) | 15 | – | – |
| III (motor examination) | 23.3 (12.4) | 15 | – | – |
| Total score | 37.7 (18.8) | 15 | – | – |
| Hoehn and Yahr | 2.0 (0.7) | 15 | – | – |
| 0.5 | – | 1 | – | – |
| 1 | – | 2 | – | – |
| 2 | – | 6 | – | – |
| 2.5 | – | 5 | – | – |
| 3 | – | 1 | – | – |
| Schwab and England | 87.9 (5.8) | 15 | – | – |
| Medication | ||||
| | 136.0 (159.3) | 14 | – | – |
| Ago LED | 253.0 (201.2) | 14 | – | – |
| Total LED | 363.0 (260.5) | 15 | – | – |
Figure 1Mean performance of IPD patients and controls in the perceptual tasks of the BAASTA. Tasks where patients differed from controls before the cueing training are selectively reported. Error bars indicate the standard error of the mean (SEM). Note: *p < 0.05; $marginally significant difference.
Figure 2Mean performance of IPD patients and controls in the motor tasks of the BAASTA. Tasks where patients differed from controls before the cueing training are selectively reported. Error bars indicate the standard error of the mean (SEM). *p < 0.05; **p < 0.01; $marginally significant difference.
Patients’ individual performances (.
| Duration discrimination | BAT | D-prime 600 ms | Paced tapping accuracy | Paced tapping accuracy | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 450 ms | 750 ms | ||||||||||||||
| Patient | Pre | Post | Follow-up | Pre | Post | Follow-up | Pre | Post | Follow-up | Pre | Post | Follow-up | Pre | Post | Follow-up |
| 1 | 2.27 | 2.04 | -0.14 | -2.16 | -2.16 | -0.58 | -0.23 | 0.43 | 0.43 | -0.28 | -0.40 | 2.28 | -0.23 | -0.48 | -0.69 |
| 2 | 0.51 | 2.43 | -0.47 | -2.30 | -2.02 | -1.15 | -1.11 | -1.11 | 0.43 | -0.46 | 0.26 | -0.04 | 0.11 | 0.04 | -0.42 |
| 3 | 0.44 | -0.14 | -0.14 | 0.72 | 0.86 | 0.86 | 0.43 | 0.43 | 0.43 | 0.43 | 0.30 | 0.33 | -0.77 | -0.90 | -0.18 |
| 4 | 0.93 | 0.57 | 0.89 | 0.72 | 0.86 | 0.43 | -0.75 | -0.23 | -0.23 | -1.00 | -0.37 | 0.18 | -0.43 | -0.61 | -0.30 |
| 5 | 1.47 | 2.23 | 0.68 | -1.87 | -1.73 | -0.43 | 0.42 | 0.43 | 0.43 | 1.22 | 0.26 | -0.85 | -0.50 | -0.69 | -0.97 |
| 6 | -1.07 | 0.47 | -0.53 | 0.00 | -0.86 | -1.30 | -1.39 | -0.23 | 0.43 | 4.56 | 1.88 | 3.54 | -0.34 | -0.46 | -0.64 |
| 7 | 0.20 | 1.18 | -0.75 | NaN | NaN | NaN | 0.43 | -2.05 | 0.43 | 1.14 | -0.53 | 0.36 | 2.30 | 0.59 | 0.40 |
| 8 | 2.27 | 3.36 | 1.62 | -2.74 | -2.16 | 0.14 | 0.43 | 0.43 | -0.75 | 6.89 | 0.79 | -0.51 | 3.86 | 0.30 | 0.38 |
| 9 | -1.16 | 0.51 | -0.59 | 0.29 | 0.43 | 0.14 | -0.23 | 0.43 | 0.43 | -0.34 | -0.24 | -1.05 | -0.59 | -0.26 | -1.02 |
| 10 | 3.32 | 2.66 | 3.52 | 0.58 | 0.86 | 0.43 | -1.11 | -0.23 | -0.10 | 1.12 | 0.71 | 2.27 | 1.93 | 8.74 | 3.25 |
| 11 | 0.23 | 2.59 | 4.30 | -4.61 | -3.74 | -2.16 | -3.78 | 0.49 | 0.43 | 4.69 | 0.12 | 3.19 | 5.12 | 2.39 | 2.45 |
| 12 | 3.48 | -0.17 | -0.56 | 0.58 | 0.00 | 0.72 | 0.43 | 0.43 | 0.43 | -0.09 | -0.80 | -0.57 | 0.21 | 0.21 | -0.74 |
| 13 | 1.07 | 3.23 | -0.24 | -0.86 | -1.30 | 0.29 | 0.43 | 0.43 | 0.43 | 1.10 | 0.79 | 2.13 | 1.78 | 1.98 | 1.82 |
| 14 | 0.64 | 0.44 | 0.47 | -2.30 | -3.89 | -3.31 | -2.79 | -3.58 | -1.39 | -0.42 | 0.58 | -0.46 | 1.17 | 1.25 | 0.46 |
| 15 | 0.93 | 0.20 | -1.00 | 0.58 | 0.29 | 0.29 | 0.43 | 0.43 | 0.43 | -1.04 | -0.11 | -0.09 | 0.04 | 0.24 | -0.46 |
Values highlighted in gray indicate significant differences between the performances of patients and of healthy controls, as assessed with corrected t-tests (Crawford and Garthwaite, .
.
Percentage of IPD patients who exhibited impaired perceptual and/or motor timing relative to healthy controls pre-, post-training, and at the follow-up.
| Pre | Post | Follow-up | |
|---|---|---|---|
| Perceptual only | 5/15 (33%) | 6/15 (40%) | 1/15 (7%) |
| Motor only | 3/15 (20%) | 1/15 (7%) | 3/15 (20%) |
| Perceptual and motor | 3/15 (20%) | 3/15 (20%) | 2/15 (13%) |
| No impairment | 4/15 (27%) | 5/15 (33%) | 9/15 (60%) |